Kratzke RA - Search Results

1

Response to the methylation inhibitor dihydro-5-azacytidine in mesothelioma is not associated with methylation of p16INK4a: results of cancer and leukemia group B 159904.

Kratzke RA, Wang X, Wong L, Kratzke MG, Green MR, Vokes EE, Vogelzang NJ, Kindler HL, Kern JA; Cancer and Leukemia Group B. Kratzke RA, et al. Among authors: kratzke mg. J Thorac Oncol. 2008 Apr;3(4):417-21. doi: 10.1097/JTO.0b013e318168da0a. J Thorac Oncol. 2008. PMID: 18379362 Free article.

2

Immunohistochemical analysis of the p16INK4 cyclin-dependent kinase inhibitor in malignant mesothelioma.

Kratzke RA, Otterson GA, Lincoln CE, Ewing S, Oie H, Geradts J, Kaye FJ. Kratzke RA, et al. J Natl Cancer Inst. 1995 Dec 20;87(24):1870-5. doi: 10.1093/jnci/87.24.1870. J Natl Cancer Inst. 1995. PMID: 7494231

3

Rb and p16INK4a expression in resected non-small cell lung tumors.

Kratzke RA, Greatens TM, Rubins JB, Maddaus MA, Niewoehner DE, Niehans GA, Geradts J. Kratzke RA, et al. Cancer Res. 1996 Aug 1;56(15):3415-20. Cancer Res. 1996. PMID: 8758904

4

Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression.

Frizelle SP, Grim J, Zhou J, Gupta P, Curiel DT, Geradts J, Kratzke RA. Frizelle SP, et al. Among authors: kratzke ra. Oncogene. 1998 Jun 18;16(24):3087-95. doi: 10.1038/sj.onc.1201870. Oncogene. 1998. PMID: 9671387

5

Adenovirus-mediated delivery of p16 to p16-deficient human bladder cancer cells confers chemoresistance to cisplatin and paclitaxel.

Grim J, D'Amico A, Frizelle S, Zhou J, Kratzke RA, Curiel DT. Grim J, et al. Among authors: kratzke ra. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2415-23. Clin Cancer Res. 1997. PMID: 9815642

6

Gene therapy of established mesothelioma xenografts with recombinant p16INK4a adenovirus.

Frizelle SP, Rubins JB, Zhou JX, Curiel DT, Kratzke RA. Frizelle SP, et al. Among authors: kratzke ra. Cancer Gene Ther. 2000 Nov;7(11):1421-5. doi: 10.1038/sj.cgt.7700241. Cancer Gene Ther. 2000. PMID: 11129284

7

Mechanisms of G1 checkpoint loss in resected early stage non-small cell lung cancer.

Zhou JX, Niehans GA, Shar A, Rubins JB, Frizelle SP, Kratzke RA. Zhou JX, et al. Among authors: kratzke ra. Lung Cancer. 2001 Apr;32(1):27-38. doi: 10.1016/s0169-5002(00)00210-5. Lung Cancer. 2001. PMID: 11282426

8

Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer--preliminary results of Cancer and Leukemia Group B Trial 9761.

D'Cunha J, Corfits AL, Herndon JE 2nd, Kern JA, Kohman LJ, Patterson GA, Kratzke RA, Maddaus MA. D'Cunha J, et al. Among authors: kratzke ra. J Thorac Cardiovasc Surg. 2002 Mar;123(3):484-91; discussion 491. doi: 10.1067/mtc.2002.119883. J Thorac Cardiovasc Surg. 2002. PMID: 11882819 Free article.

9

Inactivation of p16INK4a expression in malignant mesothelioma by methylation.

Wong L, Zhou J, Anderson D, Kratzke RA. Wong L, et al. Among authors: kratzke ra. Lung Cancer. 2002 Nov;38(2):131-6. doi: 10.1016/s0169-5002(02)00178-2. Lung Cancer. 2002. PMID: 12399123

10

Immunohistochemical detection of occult lymph node metastases in non-small cell lung cancer: anatomical pathology results from Cancer and Leukemia Group B Trial 9761.

Vollmer RT, Herndon JE 2nd, D'Cunha J, Abraham NZ, Solberg J, Fatourechi M, Maruska A, Kern JA, Green MR, Kratzke RA, Maddaus MA; Cancer and Leukemia Group B Trial 9761. Vollmer RT, et al. Among authors: kratzke ra. Clin Cancer Res. 2003 Nov 15;9(15):5630-5. Clin Cancer Res. 2003. PMID: 14654545

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters